The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab

av Kelly, Richard, Richards, Stephen, Hillmen, Peter, Hill, Anita
Publicerad 2009

The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for Patients

av Young, Neal S., Meyers, Gabrielle, Schrezenmeier, Hubert, Hillmen, Peter, Hill, Anita
Publicerad 2009

Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia

av Sajawal, Sanah, Mackie, Sarah L, Hillmen, Peter, McGonagle, Dennis
I publikationen BMJ Case Rep (2017)

Experiences in the design and implementation of phase II trials in CLL

av Cohen Dena R, Hillmen Peter, Brown Julia M, Gregory Walter M
Publicerad 2011-12-01

Experiences in the design and implementation of phase II trials in CLL

av Cohen, Dena R, Hillmen, Peter, Brown, Julia M, Gregory, Walter M
Publicerad 2011

Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program

av Hillmen, Peter, Diels, Joris, Healy, Nollaig, Iraqi, Wafae, Aschan, Johan, Wildgust, Mark
I publikationen Haematologica (2018)

DAPK3 participates in the mRNA processing of immediate early genes in chronic lymphocytic leukaemia

av Thomas, Fraser, Holmes, Katie B., Kreuz, Sarah, Hillmen, Peter, Lefevre, Pascal F.
I publikationen Mol Oncol (2020)

Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria

av Griffin, Morag, Hillmen, Peter, Munir, Talha, Richards, Stephen, Arnold, Louise, Riley, Kathryn, Hill, Anita
I publikationen Haematologica (2019)

An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects

av Alharthi, Afaf, Beck, Daniel, Howard, Dena R., Hillmen, Peter, Oates, Melanie, Pettitt, Andrew, Wagner, Simon D.
I publikationen BMC Res Notes (2018)

Telomere length predicts for outcome to FCR chemotherapy in CLL

av Norris, Kevin, Hillmen, Peter, Rawstron, Andrew, Hills, Robert, Baird, Duncan M., Fegan, Christopher D., Pepper, Chris
I publikationen Leukemia (2019)

Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization

av Hill, Anita, Rother, Russell P., Arnold, Louise, Kelly, Richard, Cullen, Matthew J., Richards, Stephen J., Hillmen, Peter
Publicerad 2010

Different Biology and Clinical Outcome According to the Absolute Numbers of Clonal B-Cells in Monoclonal B-Cell Lymphocytosis (MBL)

av Rawstron, Andy C., Shanafelt, Tait, Lanasa, Mark C., Landgren, Ola, Hanson, Curtis, Orfao, Alberto, Hillmen, Peter, Ghia, Paolo
I publikationen Cytometry B Clin Cytom (2010)

Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells

av Holmes, Katie B., Sadreev, Ildar I., Rawstron, Andy C., Munir, Tal, Westhead, David R., Hillmen, Peter, Lefevre, Pascal F.
I publikationen Oncogenesis (2019)

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly dia...

av Appleby, Niamh, Eyre, Toby A., Cabes, Maite, Jackson, Aimee, Boucher, Rebecca, Yates, Francesca, Fox, Sonia, Rawstron, Andrew, Hillmen, Peter, Schuh, Anna
I publikationen BMC Cancer (2019)

COVID‐19 infection in patients on anti‐complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience

av Pike, Alexandra, Muus, Petra, Munir, Tahla, Mitchell, Lindsay, Arnold, Louise, Riley, Kathryn, Houghton, Nicola, Forrest, Briony, Gachev, Jeanifer, Hillmen, Peter, Griffin, Morag
I publikationen Br J Haematol (2020)

A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia

av Howard, Dena R., Hockaday, Anna, Brown, Julia M., Gregory, Walter M., Todd, Susan, Munir, Tahla, Oughton, Jamie B., Dimbleby, Claire, Hillmen, Peter
I publikationen Trials (2021)

Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial

av Howard, Dena R., Munir, Talha, Hockaday, Anna, Rawstron, Andy C., Collett, Laura, Oughton, Jamie B., Allsup, David, Bloor, Adrian, Phillips, David, Hillmen, Peter
I publikationen Trials (2016)

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

av Rossi, Davide, Shadman, Mazyar, Condoluci, Adalgisa, Brown, Jennifer R., Byrd, John C., Gaidano, Gianluca, Hallek, Michael, Hillmen, Peter, Mato, Anthony, Montserrat, Emili, Ghia, Paolo
I publikationen Hemasphere (2020)

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

av Parker, Charles, Omine, Mitsuhiro, Richards, Stephen, Nishimura, Jun-ichi, Bessler, Monica, Ware, Russell, Hillmen, Peter, Luzzatto, Lucio, Young, Neal, Kinoshita, Taroh, Rosse, Wendell, Socié, Gerard
Publicerad 2005

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

av Socié, Gérard, Caby‐Tosi, Marie‐Pierre, Marantz, Jing L., Cole, Alexander, Bedrosian, Camille L., Gasteyger, Christoph, Mujeebuddin, Arshad, Hillmen, Peter, Vande Walle, Johan, Haller, Hermann
I publikationen Br J Haematol (2019)